MLYS — Mineralys Therapeutics Inc
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Mineralys Therapeutics Inc (MLYS), worth $48.93M combined. Over the quarter 0 opened or added, 3 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Polar Capital | $38.33M | 0.11% | -5.3% |
| Renaissance | $10.21M | 0.01% | -1.2% |
| Persistent | $388.78K | 0.12% | -6.4% |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.